封面
市場調查報告書
商品編碼
1304308

電感受態細胞市場:各用途,各細胞類型,性狀轉換效率,各包裝型態,各終端用戶,各地區- 市場規模,佔有率,展望,機會分析,2023-2030年

Electrocompetent Cells Market,By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態:

分子克隆研究的研究活動和資助活動有所增加。這反過來預計將增加對感受態細胞的需求,因為感受態細胞在各種生物技術程序中非常有效。這一因素預計將支持預測期內全球電感受態細胞市場的增長。

然而,對具有良好技術知識的熟練專業人員的需求是預計在預測期內阻礙全球電感受態細胞市場增長的主要因素之一。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間(2022-2030 年)之全球電感受態細胞市場的市場規模和復合年增長率(CAGR %)相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會,說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點,各類型投資組合、主要焦點、財務業績和市場策略等參數,介紹全球電感受態細胞市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察,將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球電感受態細胞市場報告配合該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球電感受態細胞市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • 連貫·機遇·地圖(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
  • 分子克隆研究的研究和資助活動的增加
  • 增加對基因治療的投資
    • 阻礙因素
  • 缺乏熟練的專業人員
    • 機會
  • 重組DNA技術的進步
  • 影響分析
  • 主要的焦點
  • 法規情勢
  • 產品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收購情勢

第4章 全球電感受態細胞市場-冠狀病毒(COVID-19)大流行病的影響

  • COVID-19流行病學
  • 供給面和需求面的分析
  • 經濟影響

第5章 電感受態細胞的全球市場,各用途,2023-2030年

  • 基因複製
  • 蛋白質表現
  • 突然變異誘發
  • 基因DNA庫建立
  • 抗體產生
  • 高通量·篩檢
  • 其他

第6章 電感受態細胞的全球市場,各細胞類型,2023-2030年

  • 大腸桿菌(E. coli)
  • 釀酒酵母(S. cerevisiae)
  • 枯草芽孢桿菌(B. subtilis)
  • 惡臭假單胞菌(P. putida)
  • 肺炎鏈球菌(S.pneumoniae)
  • 其他

第7章 電感受態細胞的全球市場,性狀轉換效率,2023-2030年

  • 高效率細胞
  • 超高效率細胞

第8章 電感受態細胞的全球市場:各包裝型態,2023-2030年

  • 自訂格式

第9章 電感受態細胞的全球市場:各終端用戶,2023-2030年

  • 製藥·生物科技企業
  • 學術·研究機關
  • 臨床研究委外機構(CRO)
  • 其他

第10章 電感受態細胞的全球市場,各地區,2023-2030年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 競爭情形

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.

第12章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5897

Electrocompetent cells are bacterial strains that are capable of receiving and transferring foreign DNA by the process of electrotransformation. They are typically prepared by a time-consuming and labor-intensive method that involves extensive washing and centrifugation, as well as maintaining the cells at an ice-cold temperature. The traditional procedure also results in a low transformation efficiency, making it difficult to generate high quality clones using this technique.

Market Dynamics:

There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells as they are highly efficacious in various biotechnology procedures. This factor is expected to support growth of the global electrocompetent cells market over the forecast period.

However, the need for skilled professionals having sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), and Cell Applications, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market

Detailed Segmentation:

  • Global Electrocompetent Cells Market, By Application:
    • Cloning
    • Protein Expression
    • Mutagenesis
    • Genomic DNA Library Construction
    • Antibody Production
    • High-Throughput Screening
    • Others
  • Global Electrocompetent Cells Market, By Cell Type
    • Escherichia coli (E. coli)
    • Saccharomyces cerevisiae (S. cerevisiae)
    • Bacillus subtilis (B. subtilis)
    • Pseudomonas putida (P. putida)
    • Streptococcus pneumoniae (S. pneumoniae)
    • Others
  • Global Electrocompetent Cells Market, By Transformation Efficiency:
    • High Efficiency Cells
    • Ultra-High Efficiency Cells
  • Global Electrocompetent Cells Market, By Packaging Format:
    • Tubes
    • Plates
    • Custom Formats
  • Global Electrocompetent Cells Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Contract Research Organizations (CROs)
    • Others
  • Global Electrocompetent Cells Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • New England Biolabs, Inc.
    • GenScript Biotech Corporation
    • Lucigen Corporation
    • Takara Bio Inc.
    • Delphi Genetics S.A.
    • IBA GmbH
    • Scarab Genomics LLC
    • Zymo Research Corporation
    • Bioline GmbH (Meridian Bioscience)
    • Cell Applications, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Cell Type
    • Market Snapshot, By Transformation Efficiency
    • Market Snapshot, By Packaging Format
    • Market Snapshot, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rise in research activities and funding activities in molecular cloning studies
  • Increasing investments in gene therapy
    • Restraints
  • Lack of skilled professionals
    • Opportunities
  • Advancements in recombinant DNA technology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Electrocompetent Cells Market , By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cloning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Mutagenesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Genomic DNA Library Construction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Antibody Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • High-Throughput Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Electrocompetent Cells Market , By Cell Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Escherichia coli (E. coli)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Saccharomyces cerevisiae (S. cerevisiae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Bacillus subtilis (B. subtilis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Pseudomonas putida (P. putida)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Streptococcus pneumoniae (S. pneumoniae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Global Electrocompetent Cells Market , By Transformation Efficiency, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Ultra-High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Global Electrocompetent Cells Market , By Packaging Format, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Tubes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Plates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Custom Formats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Global Electrocompetent Cells Market , By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

10. Global Electrocompetent Cells Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)

11. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.
  • Analyst Views

12. Section

  • Research Methodology
  • About us